ArticleAntibiotics (Basel, Switzerland)2026
Substandard and Falsified Antibiotics Seized in Belgium: Quality Control Analysis Reveals High Prevalence of WHO Watch List Molecules and Bioavailability Non-Compliance.
Celine Vanhee, Cloë Degrève, Michael Canfyn, Niels Boschmans, Bram Jacobs, Koenraad Van Hoorde, Eric Deconinck, Marie Willocx, Hans Van der Meersch, Bart Ceyssens
Abstract read
In one paragraphArticle in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Celine VanheeService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, 1050 Brussels, Belgium.ORCID 0000-0002-6634-3706 Cloë DegrèveService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, 1050 Brussels, Belgium.ORCID 0009-0008-0465-4569 Michael CanfynService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, 1050 Brussels, Belgium.
Niels BoschmansService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, 1050 Brussels, Belgium.
Bram JacobsService of Foodborne Pathogens, Scientific Direction of Infectious Diseases in Humans, Sciensano, J. Wytsmanstraat 14, 1050 Brussels, Belgium.ORCID 0000-0001-7307-9619 Koenraad Van HoordeService of Foodborne Pathogens, Scientific Direction of Infectious Diseases in Humans, Sciensano, J. Wytsmanstraat 14, 1050 Brussels, Belgium.
Eric DeconinckService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, 1050 Brussels, Belgium.ORCID 0000-0001-6980-6684 Marie WillocxService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, 1050 Brussels, Belgium.ORCID 0000-0003-4739-7511 Hans Van der MeerschFederal Agency for Medicine and Health Products, Galileelaan 5/03, 1210 Brussels, Belgium.
Bart CeyssensFederal Agency for Medicine and Health Products, Galileelaan 5/03, 1210 Brussels, Belgium.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
antibiotic quality controlantimicrobial resistancedissolution testingpharmaceutical quality assurancesubstandard and falsified medicinesWHO AWaRe classification
Identifiers
PMID41750528
PMCPMC12937437
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390